source
- STAT Health Tech examines whether wearables benefit cardiovascular patientsMario Aguilar writes in a STAT Health Tech newsletter that the issue of wearables for people with cardiovascular disease is under review. The piece notes that researchers have been studying whether…
- STAT+: Cambrian’s experimental longevity drug mimics exerciseWhat Soon-Shiong has delivered, Encanta's RSV antiviral, and other biotech news from The ReadoutSTAT · 2mo ago↗ source
- Biogen adds more immune drugs in $1B buyout of secretive startup RayTheraThe companies didn’t specify the drugs Biogen is acquiring in the deal, though patents RayThera secured provide important clues.